This paper analyses the factors that determine entry into the Swedish pharmaceuticals market. The analysis is based on panel data for 22 different substances covering the years 1972 to 1996. The results show that profit opportunities in a particular market have a positive impact on entry. In addition, there is some evidence suggesting that the length of the patent protection period has a negative impact on entry.Pharmaceutical industry; entry; number of firms; panel data
This paper investigates the dynamics of firm entry and exit with a focus on differences betweenindus...
In this thesis factors that explain Swedish pharmaceutical export as been analyzed. The period inves...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
Between the 1970s and 2009 the Swedish pharmacy market was characterized by a governmental monopoly ...
This paper examines the determinants of new pharmaceutical launches since 1980 in the G7 nations usi...
Several studies have investigated the relationship between different measures of innovative activity...
The goal of this study is to analyze the impact of innovation on entry, that is, the launch of a new...
The paper investigates the decisions of companies to enter new submarkets, analyzing the relationshi...
The pharmaceutical industry is one of Sweden’s most important export industries with 6% of total exp...
Ziel der Thesis ist herauszufinden, ob ein Markteintritt der mybacs GmbH in Schweden sinnvoll ist. H...
This work explores the factors that spur firms’ propensity to enter in international markets. Among ...
In this paper I use data on all generic drug approvals granted from 1984- 1994 to examine whether he...
This thesis consists of five individual essays and an introductory chapter. The essays are all in th...
Empirical investigations into competitive behaviour on different markets is important since it does ...
This paper examines, using a zero-inflated negative binomial regression model, what determined entry...
This paper investigates the dynamics of firm entry and exit with a focus on differences betweenindus...
In this thesis factors that explain Swedish pharmaceutical export as been analyzed. The period inves...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...
Between the 1970s and 2009 the Swedish pharmacy market was characterized by a governmental monopoly ...
This paper examines the determinants of new pharmaceutical launches since 1980 in the G7 nations usi...
Several studies have investigated the relationship between different measures of innovative activity...
The goal of this study is to analyze the impact of innovation on entry, that is, the launch of a new...
The paper investigates the decisions of companies to enter new submarkets, analyzing the relationshi...
The pharmaceutical industry is one of Sweden’s most important export industries with 6% of total exp...
Ziel der Thesis ist herauszufinden, ob ein Markteintritt der mybacs GmbH in Schweden sinnvoll ist. H...
This work explores the factors that spur firms’ propensity to enter in international markets. Among ...
In this paper I use data on all generic drug approvals granted from 1984- 1994 to examine whether he...
This thesis consists of five individual essays and an introductory chapter. The essays are all in th...
Empirical investigations into competitive behaviour on different markets is important since it does ...
This paper examines, using a zero-inflated negative binomial regression model, what determined entry...
This paper investigates the dynamics of firm entry and exit with a focus on differences betweenindus...
In this thesis factors that explain Swedish pharmaceutical export as been analyzed. The period inves...
The aim of this paper is to analyse empirically entry decisions by generic firms into markets with t...